These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25446943)
1. Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology. Öz G; Kittelson E; Demirgöz D; Rainwater O; Eberly LE; Orr HT; Clark HB Neurobiol Dis; 2015 Feb; 74():158-66. PubMed ID: 25446943 [TBL] [Abstract][Full Text] [Related]
2. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Oz G; Vollmers ML; Nelson CD; Shanley R; Eberly LE; Orr HT; Clark HB Exp Neurol; 2011 Dec; 232(2):290-8. PubMed ID: 21963649 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1. Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Oz G; Hutter D; Tkác I; Clark HB; Gross MD; Jiang H; Eberly LE; Bushara KO; Gomez CM Mov Disord; 2010 Jul; 25(9):1253-61. PubMed ID: 20310029 [TBL] [Abstract][Full Text] [Related]
6. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152 [TBL] [Abstract][Full Text] [Related]
7. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431 [TBL] [Abstract][Full Text] [Related]
8. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Kim JH; Lukowicz A; Qu W; Johnson A; Cvetanovic M Glia; 2018 Sep; 66(9):1972-1987. PubMed ID: 30043530 [TBL] [Abstract][Full Text] [Related]
9. Memantine suppresses the excitotoxicity but fails to rescue the ataxic phenotype in SCA1 model mice. Belozor OS; Vasilev A; Mileiko AG; Mosina LD; Mikhailov IG; Ox DA; Boitsova EB; Shuvaev AN; Teschemacher AG; Kasparov S; Shuvaev AN Biomed Pharmacother; 2024 May; 174():116526. PubMed ID: 38574621 [TBL] [Abstract][Full Text] [Related]
10. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease. Miranda CO; Nobre RJ; Paiva VH; Duarte JV; Castelhano J; Petrella LI; Sereno J; Santana M; Afonso S; Januário C; Castelo-Branco M; de Almeida LP Acta Neuropathol Commun; 2022 Mar; 10(1):37. PubMed ID: 35305685 [TBL] [Abstract][Full Text] [Related]
11. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability. Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411 [TBL] [Abstract][Full Text] [Related]
13. Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1). Hamel K; Moncada EL; Sheeler C; Rosa JG; Gilliat S; Zhang Y; Cvetanovic M Neurobiol Dis; 2024 Jul; 197():106530. PubMed ID: 38750673 [TBL] [Abstract][Full Text] [Related]
14. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Oz G; Iltis I; Hutter D; Thomas W; Bushara KO; Gomez CM Cerebellum; 2011 Jun; 10(2):208-17. PubMed ID: 20838948 [TBL] [Abstract][Full Text] [Related]
15. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721 [TBL] [Abstract][Full Text] [Related]
16. Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex. Luttik K; Olmos V; Owens A; Khan A; Yun J; Driessen T; Lim J Cells; 2022 Aug; 11(17):. PubMed ID: 36078042 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. Qu W; Johnson A; Kim JH; Lukowicz A; Svedberg D; Cvetanovic M J Neuroinflammation; 2017 May; 14(1):107. PubMed ID: 28545543 [TBL] [Abstract][Full Text] [Related]
18. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Cvetanovic M; Ingram M; Orr H; Opal P Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967 [TBL] [Abstract][Full Text] [Related]
19. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033 [TBL] [Abstract][Full Text] [Related]
20. Treadmill training increases the motor activity and neuron survival of the cerebellum in a mouse model of spinocerebellar ataxia type 1. Chuang CS; Chang JC; Soong BW; Chuang SF; Lin TT; Cheng WL; Orr HT; Liu CS Kaohsiung J Med Sci; 2019 Nov; 35(11):679-685. PubMed ID: 31271500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]